Research Institute of Molecular Pathology
ORCID: 0000-0002-5739-5416Publishes on RNA and protein synthesis mechanisms, CRISPR and Genetic Engineering, RNA modifications and cancer. 52 papers and 3.7k citations.
Add your photo, update your bio, and get notified when your ranking changes.
A series of salicylaldehyde azine derivatives were found to exhibit interesting aggregation-induced emission enhancement (AIEE) characteristics. In good solvent, all these compounds displayed very weak fluorescence, while strong emission was observed when they were placed in poor solvent. Moreover, the AIEE color of these compounds varied from green to red depending on the substituents on azines. Their in situ formation also promises potential applications in fluorescence sensing of hydrazine.
We present two CRISPR-mediated analog multi-event recording apparatus (CAMERA) systems that use base editors and Cas9 nucleases to record cellular events in bacteria and mammalian cells. The devices record signal amplitude or duration as changes in the ratio of mutually exclusive DNA sequences (CAMERA 1) or as single-base modifications (CAMERA 2). We achieved recording of multiple stimuli in bacteria or mammalian cells, including exposure to antibiotics, nutrients, viruses, light, and changes in Wnt signaling. When recording to multicopy plasmids, reliable readout requires as few as 10 to 100 cells. The order of stimuli can be recorded through an overlapping guide RNA design, and memories can be erased and re-recorded over multiple cycles. CAMERA systems serve as "cell data recorders" that write a history of endogenous or exogenous signaling events into permanent DNA sequence modifications in living cells.
Programmable sequence-specific genome editing agents such as CRISPR-Cas9 have greatly advanced our ability to manipulate the human genome. Although canonical forms of genome-editing agents and programmable transcriptional regulators are constitutively active, precise temporal and spatial control over genome editing and transcriptional regulation activities would enable the more selective and potentially safer use of these powerful technologies. Here, by incorporating ligand-responsive self-cleaving catalytic RNAs (aptazymes) into guide RNAs, we developed a set of aptazyme-embedded guide RNAs that enable small molecule-controlled nuclease-mediated genome editing and small molecule-controlled base editing, as well as small molecule-dependent transcriptional activation in mammalian cells.